Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration

por Packnett, Elizabeth R., Winer, Isabelle H., Oladapo, Abiola, Wojdyla, Matthew
Publicado 2023

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis

por Packnett, Elizabeth R., Zimmerman, Nicole M., Novy, Patricia, Morgan, Laura C., Chime, Nnenna, Ghaswalla, Parinaz
Publicado 2023

Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI

por Bogart, Michael, Abbott, Carl B, Bangalore, Mohan, McMorrow, Donna, Packnett, Elizabeth R, DiRocco, Kristi
Publicado 2023

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs

por Llanos, Jean-Pierre, Ortega, Hector, Bogart, Michael, Packnett, Elizabeth R, Manjelievskaia, Janna, Bell, Christopher F, Hahn, Beth
Publicado 2020

A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United States

por Packnett, Elizabeth R., Zimmerman, Nicole M., Kim, Gilwan, Novy, Patricia, Morgan, Laura C., Chime, Nnenna, Ghaswalla, Parinaz
Publicado 2022

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020

por Packnett, Elizabeth R., Winer, Isabelle H., Larkin, Heather, Oladapo, Abiola, Gonzales, Tara, Wojdyla, Matthew, Goldstein, Mitchell, Smith, Vincent C.
Publicado 2022